Top news of the week: 02.06.2020.

#CoronaVirus #biotechnology #COVID19 #CoronaPandemic #biospace #lifesciences #pharmaceuticals #CoronaOutbreak #BIODigital #therapeutics

Companies And Industries

On Jun 1, 2020
@FiercePharma shared
Special report: The top 15 highest-paid biopharma CEOs of 2019 https://t.co/YZY8uuGafG
Open

Book traversal links for The top 15 highest-paid biopharma CEOs of 2019

Book traversal links for The top 15 highest-paid biopharma CEOs of 2019

While the list of the best-paid biopharma CEOs of 2019 includes some of the world's largest drugmakers, you'll also find smaller companies among them. And the CEO at No. 1 could be a ...

On May 29, 2020
@CellCultureDish shared
The Dish’s Weekly Biotechnology News Wrap Up – May 29, 2020 https://t.co/oLXOPe4qvS
Open

The Dish’s Weekly Biotechnology News Wrap Up – May 29, 2020

The Dish’s Weekly Biotechnology News Wrap Up – May 29, 2020

This week's headlines include: Coronavirus discoveries can come along faster with adaptive clinical trials, South Africa BCG booster trials seek low-cost weapon against COVID-19, Will ...

On May 27, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: May 27 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/4FxSO5C79i
Open

Biopharma Update on the Novel Coronavirus: May 27

Biopharma Update on the Novel Coronavirus: May 27

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 27, 2020.

On Jun 1, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: June 1 #biospace #lifesciences #biotechnology #pharmaceuticals #CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic https://t.co/Hl7tNbhrMR
Open

Biopharma Update on the Novel Coronavirus: June 1

Biopharma Update on the Novel Coronavirus: June 1

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 1, 2020.

On May 27, 2020
@matthewherper shared
Moderna executives have cashed out $89M in shares this year. Some no longer hold $MRNA stock, @damiangarde writes. https://t.co/y7wbfJzTLb
Open

Moderna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes

Moderna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes

With the firm in the spotlight for its Covid-19 vaccine, five executives have initiated nearly three times as many stock transactions than in all of 2019.

On Jun 1, 2020
@BiotechWorld shared
Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action https://t.co/eXzQSkG4Sw https://t.co/J05VekOjwC
Open

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action

Legend Biotech is living up to its name as it sets terms for a massive $350 million IPO, while early-stage cancer biotech Repare Therapeutics and blood-disease-focused Forma Therapeutics ...

On May 29, 2020
@BIOConvention shared
RT @IAmBiotech: Discover @SutroBio, a clinical stage company working to develop the next generation of #therapeutics for diseases like #cancer and #autoimmune disorders. Learn more in our latest #BeyondImagination feature at @BIOConvention’s #BIODigital. https://t.co/Sgr2Exmbsf https://t.co/jUj24t408q
Open

The Next Generation of Cancer Therapeutics

The Next Generation of Cancer Therapeutics

Our Biotechnology: Beyond Imagination series highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today’s feature is Sutro ...

On May 26, 2020
@IAmBiotech shared
[email protected]: Novavax launches its first #coronavirus #vaccine test on humans https://t.co/aYOxEOkuCY
Open

Novavax launches its first coronavirus vaccine test on humans

Novavax launches its first coronavirus vaccine test on humans

U.S. biotech company Novavax Inc has joined the race to test coronavirus vaccine candidates on humans and said it was targeting production of over a billion doses of its vaccine candidate ...